Transplacental non-steroidal anti-inflammatory drugs versus expectant management in fetal Ebstein anomaly with circular shunt: Systematic review and meta-analysis.
Journal
Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540
Informations de publication
Date de publication:
30 Oct 2023
30 Oct 2023
Historique:
revised:
11
09
2023
received:
19
04
2023
accepted:
14
09
2023
medline:
30
10
2023
pubmed:
30
10
2023
entrez:
30
10
2023
Statut:
aheadofprint
Résumé
Ebstein anomaly (EA) is a rare congenital cardiac malformation associated with high perinatal mortality. In this systematic review and meta-analysis, we aimed to investigate the outcomes of pregnancies affected by EA or tricuspid valve dysplasia (TVD) with circular shunt, focusing on two prenatal management approaches: (1) expectant management (EM) and (2) transplacental non-steroidal anti-inflammatory drugs (NSAID) therapy. We searched PubMed, Scopus, and Web of Science systematically from its inception until June 2023. The random-effect model was used to pool the data. Heterogeneity was assessed using the I
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd.
Références
Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004;147(3):425-439. https://doi.org/10.1016/j.ahj.2003.05.003
Freud LR, Escobar-Diaz MC, Kalish BT, et al. Outcomes and predictors of perinatal mortality in fetuses with Ebstein anomaly or tricuspid valve dysplasia in the current era: a multicenter study. Circulation. 2015;132(6):481-489. https://doi.org/10.1161/circulationaha.115.015839
Anderson KR, Zuberbuhler JR, Anderson RH, et al. Morphologic spectrum of Ebstein's anomaly of the heart: a review. Mayo Clin Proc. 1979;54(3):174-180.
Jost CHA, Connolly HM, Dearani JA, et al. Ebstein’s Anom. 2007;115(2):277-285.
Celermajer DS, Cullen S, Sullivan ID, Spiegelhalter DJ, Wyse RK, Deanfield JE. Outcome in neonates with Ebstein's anomaly. J Am Coll Cardiol. 1992;19(5):1041-1046. https://doi.org/10.1016/0735-1097(92)90291-t
Giuliani ER, Fuster V, Brandenburg RO, et al. Ebstein's anomaly: the clinical features and natural history of Ebstein's anomaly of the tricuspid valve. Mayo Clin Proc. 1979;54(3):163-173.
Andrews RE, Tibby SM, Sharland GK, Simpson JM. Prediction of outcome of tricuspid valve malformations diagnosed during fetal life. Am J Cardiol. 2008;101(7):1046-1050. https://doi.org/10.1016/j.amjcard.2007.11.049
Wertaschnigg D, Manlhiot C, Jaeggi M, et al. Contemporary outcomes and factors associated with mortality after a fetal or neonatal diagnosis of Ebstein anomaly and tricuspid valve disease. Can J Cardiol. 2016;32(12):1500-1506. https://doi.org/10.1016/j.cjca.2016.03.008
Sasikumar D, Sasidharan B, Sivasubramanian S. Demonstration of circular shunt in fetal Ebstein anomaly. Ann Pediatr Cardiol. 2015;8(3):249-250. https://doi.org/10.4103/0974-2069.154155
Torigoe T, Mawad W, Seed M, et al. Treatment of fetal circular shunt with non-steroidal anti-inflammatory drugs. Ultrasound Obstet Gynecol. 2019;53(6):841-846. https://doi.org/10.1002/uog.20169
Zimmer EZ, Blazer S, Lorber A, Solt I, Egenburg S, Bronshtein M. Fetal Ebstein's anomaly: early and late appearance. Prenat Diagn. 2012;32(3):228-233. https://doi.org/10.1002/pd.2935
Selamet Tierney ES, McElhinney DB, Freud LR, et al. Assessment of progressive pathophysiology after early prenatal diagnosis of the Ebstein anomaly or tricuspid valve dysplasia. Am J Cardiol. 2017;119(1):106-111. https://doi.org/10.1016/j.amjcard.2016.09.022
Freud LR, McElhinney DB, Kalish BT, et al. Risk factors for mortality and circulatory outcome among neonates prenatally diagnosed with ebstein anomaly or tricuspid valve dysplasia: a multicenter study. J Am Heart Assoc. 2020;9(21):e016684. https://doi.org/10.1161/jaha.120.016684
Yu JJ, Yun TJ, Won HS, et al. Outcome of neonates with Ebstein's anomaly in the current era. Pediatr Cardiol. 2013;34(7):1590-1596. https://doi.org/10.1007/s00246-013-0680-x
Pavlova M, Fouron JC, Drblik SP, et al. Factors affecting the prognosis of Ebstein's anomaly during fetal life. Am Heart J. 1998;135(6 Pt 1):1081-1085. https://doi.org/10.1016/s0002-8703(98)70076-6
Cieplucha A, Trojnarska O, Bartczak-Rutkowska A, et al. Severity scores for Ebstein anomaly: credibility and usefulness of echocardiographic vs magnetic resonance assessments of the celermajer index. Can J Cardiol. 2019;35(12):1834-1841. https://doi.org/10.1016/j.cjca.2019.08.003
Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol. 1994;23(1):170-176. https://doi.org/10.1016/0735-1097(94)90516-9
Freud LR, Wilkins-Haug LE, Beroukhim RS, et al. Effect of in utero non-steroidal anti-inflammatory drug therapy for severe Ebstein anomaly or tricuspid valve dysplasia (NSAID therapy for fetal Ebstein anomaly). Am J Cardiol. 2021;141:106-112. https://doi.org/10.1016/j.amjcard.2020.11.013
Gill K, Arbic N, Seed M, Honjo O, Ryan G, Jaeggi E. Inadvertent irreversible closure of arterial duct following therapeutic use of transplacental indomethacin in a fetus with severe Ebstein's anomaly and circular shunt. Ultrasound Obstet Gynecol. 2021;58(6):940-942. https://doi.org/10.1002/uog.24758
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. https://doi.org/10.1016/j.ijsu.2021.105906
Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014;14(1):579. https://doi.org/10.1186/s12913-014-0579-0
Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review. J Med Libr Assoc. 2018;106(4):420-431. https://doi.org/10.5195/jmla.2018.345
Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses; 2000.
Aromataris E, Munn Z, eds. JBI Manual for Evidence Synthesis. JBI; 2020. https://synthesismanual.jbi.global
R Core Team. A Language and Environment for Statistical Computing; 2013.
Team RJUhwrc. RStudio: Integrated Development Environment for R. RStudio, PBC; 2020.2020.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14(1):135. https://doi.org/10.1186/1471-2288-14-135
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evidence-Based Ment Health. 2019;22(4):153-160. https://doi.org/10.1136/ebmental-2019-300117
Harrer M, Cuijpers P, Furukawa T, et al. Doing Meta-Analysis with R: A Hands-On Guide. Chapman and Hall/CRC; 2021.
Lopes LM, Bezerra RF, da Silva JP, da Fonseca da Silva L. Critical Ebstein's anomaly with circular shunt: from successful fetal therapy with non-steroidal anti-inflammatory drugs to biventricular repair using Da Silva cone technique. Cardiol Young. 2021;31(6):1039-1042. https://doi.org/10.1017/s1047951121000081
Wald RM, Adatia I, Van Arsdell GS, Hornberger LK. Relation of limiting ductal patency to survival in neonatal Ebstein's anomaly. Am J Cardiol. 2005;96(6):851-856. https://doi.org/10.1016/j.amjcard.2005.05.035
Barre E, Durand I, Hazelzet T, David N. Ebstein's anomaly and tricuspid valve dysplasia: prognosis after diagnosis in utero. Pediatr Cardiol. 2012;33(8):1391-1396. https://doi.org/10.1007/s00246-012-0355-z
Gottschalk I, Gottschalk L, Stressig R, et al. Ebstein's anomaly of the tricuspid valve in the fetus - a multicenter experience. Ultraschall Med. 2017;38(4):427-436. https://doi.org/10.1055/s-0042-107151
Hakim K, Boussaada R, Ayari J, et al. [Circular shunt in the severe neonatal form of Ebstein's Anomaly. The prostaglandine infusion is it beneficial or harmful?]. Cardiol Tunis. 2013;9(4):73-76.
Inamura N. Dynamic slow-motion display in the diagnosis of functional pulmonary atresia in fetal Ebstein anomaly. CASE. 2020;4(2):57-58. https://doi.org/10.1016/j.case.2019.07.009
Lasa JJ, Tian ZY, Guo R, Rychik J. Perinatal course of Ebstein's anomaly and tricuspid valve dysplasia in the fetus. Prenat Diagn. 2012;32(3):245-251. https://doi.org/10.1002/pd.2939
Masoller N, Gómez Del Rincón O, Herraiz I, et al. Prediction of perinatal mortality in Ebstein's anomaly diagnosed in the second trimester of pregnancy. Fetal Diagn Ther. 2020;47(8):604-614. https://doi.org/10.1159/000504979
Rato J, Sousa AR, Teixeira A, Anjos R. Ebstein's anomaly with 'reversible' functional pulmonary atresia. BMJ case Rep. 2019;12(12):e229809. https://doi.org/10.1136/bcr-2019-229809
Satomi G, Momoi N, Kikuchi N, Nakazawa M, Momma K. Prenatal diagnosis and outcome of Ebstein's anomaly and tricuspid valve dysplasia in relation to lung hypoplasia. Echocardiography. 1994;11(3):215-220. https://doi.org/10.1111/j.1540-8175.1994.tb01070.x
Sharland GK, Chita SK, Allan LD. Tricuspid valve dysplasia or displacement in intrauterine life. J Am Coll Cardiol. 1991;17(4):944-949. https://doi.org/10.1016/0735-1097(91)90877-c
Suneja A, Nalini, Agarwal N, Gupta S, Dev G, Jain N. Fetal Ebstein anomaly--a rare cause of non-immune hydrops. Indian J Pediatr. 1996;63(6):812-815. https://doi.org/10.1007/bf02730935
Tongsong T, Chanprapaph P, Khunamornpong S, Sirichotiyakul S. Sonographic features of Ebstein anomaly associated with hydrops fetalis: a report of two cases. J Clin Ultrasound. 2005;33(3):149-153. https://doi.org/10.1002/jcu.20102
Torigoe F, Ishida H, Ishii Y, et al. Fetal echocardiographic prediction score for perinatal mortality in tricuspid valve dysplasia and Ebstein's anomaly. Ultrasound Obstet Gynecol. 2020;55(2):226-232. https://doi.org/10.1002/uog.20302
Tsukimori K, Morihana E, Fusazaki N, Takahata Y, Oda S, Kado H. Critical Ebstein anomaly in a fetus successfully managed by elective preterm delivery and surgical intervention without delay after birth. Pediatr Cardiol. 2012;33(2):343-346. https://doi.org/10.1007/s00246-011-0124-4
Stulak JM, Dearani JA, Danielson GK. Surgical management of Ebstein's anomaly. In: Seminars in thoracic and cardiovascular surgery Pediatric cardiac surgery annual; 2007:105-111.
Powel JE, Kraus E, Reddy C, Lannaman K. Treatment of severe fetal Ebstein's anomaly with prenatal nonsteroidal anti-inflammatory therapy. Fetal Diagn Ther. 2022;49(5-6):245-249. https://doi.org/10.1159/000525593
Hickok DE, Hollenbach KA, Reilley SF, Nyberg DA. The association between decreased amniotic fluid volume and treatment with nonsteroidal anti-inflammatory agents for preterm labor. Am J Obstet Gynecol. 1989;160(6):1525-1530. discussion 1530-1521. https://doi.org/10.1016/0002-9378(89)90880-6
Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal antiinflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40(5):824-829. https://doi.org/10.1345/aph.1g428
Campbell S, Clohessy A, O'Brien C, Higgins S, Higgins M, McAuliffe F. Fetal anhydramnios following maternal non-steroidal anti-inflammatory drug use in pregnancy. Obstet Med. 2017;10(2):93-95. https://doi.org/10.1177/1753495x16686466
Topuz S, Has R, Ermiş H, et al. Acute severe reversible oligohydramnios induced by indomethacin in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Exp Obstet Gynecol. 2004;31(1):70-72.
Shen O, Rabinowitz R, Lavie O, et al. Good fetal outcome following prolonged indomethacin induced anhydramnios. Case report. J Perinat Med. 1995;23(3):233-236.
Arunamata A, Axelrod DM, Bianco K, Balasubramanian S, Quirin A, Tacy T. Chronic antepartum maternal hyperoxygenation in a case of severe fetal Ebstein's anomaly with circular shunt physiology. Ann Pediatr Cardiol. 2017;10(3):284-287. https://doi.org/10.4103/apc.apc_20_17
Schidlow DN, Donofrio MT. Prenatal maternal hyperoxygenation testing and implications for critical care delivery planning among fetuses with congenital heart disease: early experience. Am J Perinatol. 2018;35(1):16-23. https://doi.org/10.1055/s-0037-1603991